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Background and objective: The Penn Facial Pain Scale (Penn-FPS) was originally developed 
as a supplemental module to the Brief Pain Inventory Pain Interference Index (BPI-PII) in order 
to fully assess the impact of trigeminal neuralgia (TN) pain on patients’ health-related quality 
of life (HRQoL). The current objective is to create and establish the content validity of a new 
stand-alone version of the measure, the Penn-FPS-Revised (Penn-FPS-R).
Methods: Twenty participants (15 USA and 5 UK) with confirmed TN engaged in concept elici-
tation and cognitive debriefing interviews. These semi-structured interviews allowed participants 
to spontaneously describe the ways in which TN impacts on HRQoL and report on the extent to 
which the Penn-FPS and BPI-PII measure concepts are most relevant to them. Participants were 
also asked to report on the suitability of the instructions, recall period, and response options.
Results: Concept elicitation revealed nine themes involving TN restrictions on daily activities 
and HRQoL, including: “talking,” “self-care,” “eating,” “eating hard foods/chewing foods,” 
“daily activities,” “activities with temperature change,” “touching,” “mood,” and “relationships.” 
Cognitive debriefing confirmed that all of the Penn-FPS concepts and some of the BPI-PII con-
cepts (“mood,” “general activities,” and “relations with others”) were relevant, although some 
items required edits to better capture individuals’ experiences. The impact of temperature and/
or weather on activities was also identified as an important concept that is not captured by the 
Penn-FPS or BPI-PII. Participants confirmed the acceptability of recall period, instructions, and 
response options. Results from the interviews were applied to create the Penn-FPS-R, a new 
brief outcome measure that assesses the impacts of TN most important to patients.
Conclusion: The Penn-FPS-R is a new 12-item HRQoL outcome measure with content validity 
that can be used to assess and monitor the impact of TN treatment interventions in both clinical 
practice and research.
Keywords: content validity, concept elicitation, cognitive debriefing, Penn Facial Pain Scale, 
trigeminal neuralgia, PRO development, patient reported outcome
Introduction
Trigeminal neuralgia (TN) is an uncommon neuropathic disorder characterized by 
debilitating episodic facial pain.1–3 The International Association for the Study of Pain 
defines TN as “sudden, usually unilateral, severe, brief, stabbing, recurrent episodes 
of pain in the distribution of one or more branches of the trigeminal nerve.”4 Histori-
cally, TN has been called the “suicide disease” because of the severe pain associated 
with the condition.5 
Excruciating pain severity is considered intractable or difficult to treat and can be 
triggered by normal activities, such as talking, chewing, and swallowing.6 The impact 
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of pain on patients with TN includes a decreased quality 
of life and impaired daily functioning, which indicates that 
TN pain is a substantial burden to patients.6–8 The disease 
burden may result from suboptimal management strategies, 
complications from treatments, and resistance of TN to 
treatment. Therefore, in assessing the success of treatment, 
measuring impact on health-related quality of life (HRQoL) 
is an important end point. 
Robust outcome measures are needed to assess and 
monitor the impact of treatment interventions. Until recently, 
however, no TN-specific measures existed. The original Penn 
Facial Pain Scale (Penn-FPS; previously called the Brief 
Pain Inventory – Facial,9–11 then renamed Penn-FPS12) was 
designed to fill this need. The Penn-FPS was developed as a 
supplemental module to the Brief Pain Inventory Pain Inter-
ference Index (BPI-PII).9–11 The Penn-FPS assesses interfer-
ence with activities of daily living specific to TN. The scale’s 
psychometric properties are evidenced with strong reliability 
and validity.10,12 Advantages of the Penn-FPS include its 
disease-specific questions, practical administration verbally 
or on paper, and its comprehensive assessment of impact of 
TN on daily activities,12 which mirrors the concerns raised 
by TN patients who were interviewed about living with TN.13 
The Penn-FPS helped expand and advance the impact 
assessment of TN on affected individuals. However, it has 
limitations that are important to address. Most importantly, 
content validity cannot be confirmed because patients were 
not involved in development of the items. According to the 
Food and Drug Administration Guidance for Industry on 
Patient Reported Outcomes,14 content validity is a crucial 
part of measure development and insures that all concepts of 
interest from patients are incorporated in the measure. This 
is an essential first step as any additional psychometrics only 
build upon that foundation. Second, even though the BPI-PII 
only includes 7 items, it is likely that not all are relevant to 
participants with TN. For example, TN would not be expected 
to have an impact on “walking ability.”
The purpose of the current research is to understand 
what aspects of TN pain are most important to individuals 
with TN, and to use that information to potentially modify 
the existing Penn-FPS to create a new, stand-alone outcomes 
measure with content validity. 
Methods
study design and conduct 
This study employed a qualitative research approach 
with semi-structured interviews,15,16 which allowed for 
the best exploration of participants’ subjective thoughts 
and  experience of living with TN. Ethical review boards 
(Copernicus Group Independent Review Board, Cary, NC, 
USA; University College London, London, UK) approved 
the study and study documents. The study was performed 
in accordance with the Declaration of Helsinki and US 21 
Code of Federal Regulations.17 Participants received a small 
stipend for their participation.
Patient eligibility 
Eligible participants were between the ages of 18 and 80 
years with a confirmed clinical diagnosis of TN (of at least 
3 months). Participants must have experienced painful TN 
paroxysms within the past 14 days (rated at an intensity of 4 
or more on the pain numeric rating scale [NRS] and between 
a fraction of a second to 2 minutes in duration). The pain was 
required to have at least one of the following characteristics: 
“intense,” “sharp,” “superficial,” or “stabbing.” The pain could 
not be attributed to another neurological deficit or disorder. 
Patients were identified through the UK TN Association 
and clinical databases in the USA (sites in New Orleans, LA; 
St Louis, MO; and Baltimore, MD). All participants were 
required to sign and date an informed consent document 
before being enrolled onto the study. Before entering the 
study, treating clinicians were required to confirm eligibility. 
All data were de-identified before analysis. The variation in 
site location was included to maximize geographic diver-
sity and to allow for a broad spectrum of participants to be 
recruited for the study. The interviews were conducted at a 
place most convenient to the participant, either at his or her 
local clinic or at an interview facility. 
interviews
All interviews were semi-structured, conducted face-to-face 
by an experienced interviewer, and took no more than 60 
minutes.15,16 The first half of the interview involved concept 
elicitation and the second half involved the participant com-
pleting and cognitively debriefing the Penn-FPS and BPI-PII. 
The initial part of the discussion was open-ended and 
focused on eliciting information about the impact of TN on 
HRQoL, and included questions such as: “Can you tell me 
a couple of general things about living with trigeminal neu-
ralgia?”, “Describe how having trigeminal neuralgia impacts 
your life?”, and “What specifically has been impacted in your 
life due to your trigeminal neuralgia?” The second half of the 
interview acted as a cognitive debrief of the BPI-PII and the 
Penn-FPS (Figure 1), and included questions such as: “What 
were you thinking about when answering this question?” and 
“How easy or difficult was it to choose a response?”
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analytic approach
All interviews were transcribed verbatim and analyzed using 
thematic analysis18 in ATLAS.ti Version 7.0. Thematic analy-
sis is an approach that is widely used in the health sciences 
and is well accepted as a valid approach.18 The accuracy of 
thematic analysis was confirmed by comparing independent 
themes of different researchers on a selection of transcripts. 
There was a high level of agreement about the major themes 
to be retained and information that was not supported. 
Results
Demographic information
In total, 20 participants completed the study, 15 in the USA 
and 5 in the UK. Participant ages ranged from 43 to 72 years, 
with a mean of 57.5 years (SD=8.64). There were 3 males and 
17 females. Participants were identified as American Indian 
(n=1, 5%), African American/Hispanic (n=1, 5%), African 
American (n=5, 25%), and Caucasian (n=13, 65%). Over 
the previous 2 weeks, mean pain was 6.85 (SD=2.34) on a 
0–10 point NRS, where 0 was “no pain” and 10 was “worst 
pain imaginable.” Participants varied widely when describing 
the longest period of remission, with reports ranging from 5 
minutes to 13 months. 
All participants were receiving treatment for TN. A wide 
range of medications were prescribed, with the most common 
being gabapentin (n=7, 35%) and carbamazepine (n=3, 15%). 
Despite high average pain scores, the clinicians reported 
that the medication being taken was effective at treating the 
pain of most participants (n=13, 65%). Most participants 
(n=8, 40%) had undergone surgery to treat their TN. Of the 
8 participants, 3 (37.5%) had microvascular decompression, 
2 (25%) had a stereotactic radiosurgery, 1 (12.5%) had a 
craniotomy (additional detail not provided by clinician), 
1 (12.5%) had a cyber-knife procedure, and 1 (12.5%) par-
ticipant had cryosurgery.
concept elicitation
Thematic analysis of participants’ spontaneous reports 
revealed 9 TN pain-related HRQoL impacts. Seven were 
focused on daily activities (“talking,” “self-care,” “eating,” 
“eating hard foods/chewing foods,” “daily activities,” “activi-
ties with temperature change,” and “touching”) and 2 related 
to “mood” and “relationships” impacts. Participants’ quotes 
are presented in Table 1. There was no difference between US 
and UK cohorts, with regard to concepts discussed. 
Cognitive debriefing of BPI-PII
Three items from the BPI-PII were identified as relevant to 
all individuals with TN and were supported in the concept 
elicitation section: “general activities,” “mood,” and “rela-
tions with other people.” Based on feedback, these were 
rephrased as “daily activities (for example, work, exercise, 
and housework),” “mood (the way you are feeling),” and 
“relationships (for example, friends, family, partners, etc.),” 
respectively. The items that were not relevant included: 
“walking ability,” “normal work,” “sleep,” and “enjoyment 
of life.” All participants highlighted that it was easy to 
complete and understand, with suitable response options 
and recall period. 
Cognitive debriefing of Penn-FPS
Participants suggested that all concepts in the Penn-FPS were 
relevant, although minor amendments were necessary to 
improve relevance on some items. Participant feedback indi-
cated that the item “eating hard foods” should be rephrased 
to “biting and chewing” and the item “touching your face 
BPI-PII – seven items
•	 General	activity,	mood,	walking	ability,	normal	work,	relations	with	other	people,	sleep,	and	enjoyment	of	life
•	 Response	scale:	0–10	NRS	(does	not	interfere	to	completely	interferes)
•	 Recall	period	“past	week”
Penn-FPS – seven items
•	 Eating	a	meal,	touching	your	face	(grooming),	brushing	or	flossing	your	teeth,	smiling	or	laughing,	talking,	
opening	your	mouth	wide,	eating	hard	foods	like	apples
•	 Response	scale:	0–10	NRS	(does	not	interfere	to	completely	interferes)
•	 Recall	period	“past	week”
Figure 1 Measures to be debriefed.
Abbreviations: BPi-Pii, Brief Pain inventory Pain interference index; nRs, numeric rating scale; Penn-FPs, Penn Facial Pain scale.
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(including grooming)” should be separated into two items: 
“self-care (including washing face or hair, shaving, applying 
makeup)” and “touching your face (including moving stray 
hairs, hugging, kissing, itching).” In addition, based on partici-
pants’ discussion during concept elicitation and feedback on 
the measure, a new item capturing the impact of weather and 
temperature change was added (“Activities with  temperature 
change [moving outside, between air-conditioned rooms]”); for 
example: “I think an important question would be, umm, how 
the weather affects pain cause that’s defiantly a factor when 
you have TN. Because the wind and the cold, um, just that’s 
a trigger for everyone” [site ID 01; participant ID 004]. All 
participants highlighted that the measure was easy to complete, 
understand, had a suitable recall period and response options. 
Table 1 concept elicitation themes
Theme Example quote Number of 
participants
Talking “actually, um, well, well, uh … i couldn’t talk at all but that, that was a phase i went through. i had 
to write everything.” P03-002
“talking was really painful … i could barely speak at times.” P02-003
“Talking, absolutely [affected]. … i was able to carry on with my work was actually, erm, using, erm, 
google hangout, but rather than speaking, typing.” P04-005
15/20
self-care “Well, brushing and flossing can be excruciating … washing my face, putting moisturizing creams on 
my face [provokes an attack] … i try to never touch my face.” P02-003
“Washing my face can be a challenge because it … This, the side of my face is very sensitive when 
it’s active, and so i just, i just have to really be cautious about it.” P01-005
“cleaning teeth, washing your face, well, itching [impacted].” P04-003
17/20
eating “eating in general [is affected], and that’s the, i try to eat soft foods like oatmeal. … i had an attack 
one time and i said, okay, let me try eating, eating some soup and the salt in the soup triggered it.” 
P03-002
“it [eating], it agitates my face … You know from the chewing, like moving your mouth.” P03-001
“i puree my foods so i don’t go socially anywhere, out to dinner. Um, nobody understands it.” P01-006
19/20
eating hard foods “hmm, an apple probably is okay. Um, sometimes it’s tough to eat, uh, meat, something that requires 
more chewing … i mean to me, biting into an apple, yes, that’s hard, but to me, eating an apple is 
not as hard as eating a steak or chewing a salad.” P01-005
“if you can’t eat a meal, you can’t eat apples [or other hard foods] … it’s such a no-no as far as Tn 
is concerned, eating hard foods even when they haven’t got the pain.” P04-002
“when i’m having an episode, i can’t eat anything, whether it be hard, soft, or whatever.” P04-0005 
12/20
Touching “i try to never touch my face.” P02-003
“you can’t touch your face.” P03-002
“somebody will come up to me and go to give me a hug and i’m lurching back away from them [for 
fear of touching my face].” P04002
11/20
activities with 
temperature change
“[the number of attacks] it depends on the weather … i could go outside right now and not a thing 
happen. it could, and the wind could be blowing or i could go outside and it could bring me to my 
knees because it’s so bad.” P01-006
“air conditioning [trigger] … and cold weather [trigger] … Winter is not, wintertime is not a 
good time for me … and like i said, summertime is good for me and the heat, but in and out of air 
conditioning buildings it’s, it flares up again, it’s the cold.” P03-001 
8/20
Daily activities “i have to be completely drugged to do the dishwasher or a load of laundry or, um, any kind of … 
putting sheets on the bed, and i could go through all of that and nothing ever happened, and i’ll go to 
sit down, and it will hit me. Or it won’t. You, you don’t know.” P01-006
“so it, it can very much interfere with your daily activities. hm.” P03-002
“Because i did have an attack at a grocery store and, but it lasted for like maybe 5 minutes and all i 
could do was just hold on to the basket.” P01-008
15/20
Mood “My mood, oh, yeah, god, absolutely. (laughter) i mean, you know, you just hit rock bottom.” P04-005
“Um, i, i, i think it’s depressed, my mood.” P01-011
“i have no life … My mood, there is no mood. There’s either you keep trying or you give up. Money 
will run out and i’ll have to give up soon.” P01-006
13/20
Relationships “i mean just like the little simple stuff you know [restricted due to Tn] i mean, i can’t like, i mean i 
don’t see anybody, i don’t have a boyfriend you know or anything like that.” P01-009
“on relationships is that suddenly i have become an ill person, whereas i wasn’t, you know … it’s 
probably easier for me, as a sufferer, than it is for them [husband and kids] to see my suffering.” 
P04-005
14/20
Note: “P” indicates participant; the first two digits refer to the site ID whilst the final 3 digits refer to the participant ID number.
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Measure development
Results were applied to create the new 12-item Penn-FPS-R 
(Table 2). One minor change to the instructions was added to 
increase clarity. The new instructions are “Circle the ONE num-
ber that best describes how much, during the past week, your 
pain has interfered with …” (versus “Circle the ONE number 
that best describes how, during the past week, pain has interfered 
with your …”). No changes were made to the 1-week recall 
period or response options as participants confirmed that the 
current format was acceptable. Table 2 details item development.
Discussion
Sound outcome measures are needed to assess the impact of 
new treatment interventions in clinical practice and research. 
The current research built upon previous work with the Penn-
FPS and supported the development of a new stand-alone 
TN outcome measure with established content validity. This 
research confirms that the new 12-item Penn-FPS-R is easily 
understood and completed by individuals with TN, and fur-
ther, that it captures all important concepts related to TN pain 
interference on HRQoL and daily functioning.  Interviews 
Table 2 Penn-FPs-R items based on participant interviews
Items Amendment New Penn Facial Pain Scale-
Revised*
Item order
Penn Facial Pain Scale*
eating a meal Remain unchanged. Identified in concept elicitation as eating eating a meal 4
Touching your face 
(including grooming)
Remain and edited. Identified in concept elicitation as 
touching and self-care. separated into touching face and 
self-care items separately
Touching your face (including 
moving stray hairs, hugging, 
kissing, itching)
6
Brushing or flossing your 
teeth
Remain unchanged. Identified in concept elicitation under 
self-care
Brushing or flossing your teeth 8
smiling or laughing Remain unchanged. Not identified in concept elicitation, 
supported in cognitive debrief
smiling or laughing 9
Talking Remain unchanged. Identified in concept elicitation as 
talking
Talking 10
Opening your mouth 
widely
Remain unchanged. Not identified in concept elicitation, 
supported in cognitive debrief
Opening your mouth widely 11
eating hard foods like 
apples
Removed. Participants highlighted that biting or chewing 
was more relevant
Removed n/a
new item new item. Based on participants’ feedback to eating hard 
foods question
Biting or chewing 5
new item new item. Based on concept elicitation the item touching 
face (including grooming) has been separated into self-care 
and touching face to better reflect concept elicitation
self-care (including washing 
face or hair, shaving, applying 
makeup)
7
new item new item based on concept elicitation outside/weather activities with temperature 
change (moving outside, 
between air-conditioned rooms)
12
BPI-PII**
general activity Clearly identified in concept elicitation as daily activities
Amended to reflect this more specific wording
Daily activities (for example, 
work, exercise, and housework)
1
Mood Clearly identified in concept elicitation
amended to add clarity
Mood (the way you are feeling) 2
Relations with other 
people
Clearly identified in concept elicitation 
amended to add clarity using participants’ own examples
Relationships (for example, 
friends, family, partners, etc.)
3
Walking ability Removed, not clearly identified in concept elicitation nor 
supported during cognitive debrief 
Removed n/a
normal work 
(includes both inside and 
outside the home and 
housework)
Removed, not clearly identified in concept elicitation nor 
supported during cognitive debrief 
Removed n/a
sleep Removed, not clearly identified in concept elicitation nor 
supported during cognitive debrief
Removed n/a
enjoyment of life Removed, not clearly identified in concept elicitation nor 
supported during cognitive debrief 
Removed n/a
Notes: *The content of the Penn Facial Pain scale and the Penn Facial Pain scale-Revised is included here with permission of John YK lee. copyright © John YK lee. **BPi 
copyright held by charles s cleeland, 1991. The items in column 1 under BPi-Pii have been replicated to show how the Penn-FPs has been decoupled from the BPi with 
permission of charles s cleeland. The items are replicated from: cleeland cs, Ryan KM. Pain assessment: global use of the Brief Pain inventory. Ann Acad Med Singapore. 
1994;23(2):129–138.19
Abbreviations: BPi-Pii, Brief Pain inventory Pain interference index; n/a, not applicable.
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were undertaken with 20 participants, which, given the nature 
of this rare condition, is a large sample and should provide 
confidence in the results. There were no differences identi-
fied between the UK and US cohorts, therefore, the measure 
content is appropriate for both countries.
The Penn-FPS-R retains all the concepts measured in 
the original version plus a new item assessing the impact 
of weather/temperature. The Penn-FPS-R also includes 3 
of the 7 concepts assessed by the BPI-PII: “daily activities 
(for example, work, exercise, and housework),” “mood (the 
way you are feeling),” and “relationships (for example, 
friends, family, partners, etc.).” Minor edits were required to 
improve the sensitivity of some specific items. For example, 
the original Penn-FPS had one item on “touching your face 
(including grooming).” Interviews suggested that this item 
would be improved by breaking it into two separate questions 
involving “touching your face (including moving stray hairs, 
hugging, kissing, itching)” and “self-care (including wash-
ing face or hair, shaving, applying makeup).” The original 
Penn-FPS also included an item on the impact of “eating 
hard food.” Participants indicated that the item would more 
accurately capture their experience if it assessed the impact 
of foods that were difficult to chew or bite. More specific-
ity was also needed to accurately assess the impact of pain 
on “social relationships.” Participants emphasized that TN 
adversely affected relationships that involved kissing and/or 
being with others who were close enough to bump against 
their faces, which was addressed by addition of the item 
“touching your face (including moving stray hairs, hugging, 
kissing, itching)” and clarification of the item “relationships 
(for example, friends, family, partners, etc.).” By refining 
some specific items and decoupling the Penn-FPS from the 
BPI-PII, the resulting Penn-FPS-R represents a shorter and 
more relevant outcomes assessment option in TN.
The adequacy of any patient reported outcome instrument 
(whether existing, modified, or newly developed) as a measure 
to support medical product labeling claims depends on whether 
its characteristics, conceptual framework, content validity, and 
other measurement properties are satisfactory.14 Content valid-
ity is the extent to which the instrument measures the concept 
of interest. With the existing Penn-FPS, it cannot be assumed 
that it has content validity since patients were not involved in 
instrument development. This new qualitative work provides 
documentation of content validity for the Penn-FPS-R since 
patient interviews were conducted using open-ended meth-
ods to elicit patient input. The findings of this study provide 
evidence that the Penn-FPS-R measures the concepts of most 
importance to patients. Furthermore, this research confirms that 
the items and domains are appropriate and comprehensive rela-
tive to its intended measurement concept, population, and use. 
The results of this study clearly show the high disease 
burden of this condition, which mirrors previous research.5–7 
It also highlights that patients report a range of avoidance 
behaviors for fear of triggering their pain.8 Despite patients 
receiving current or past treatments, the average pain was 
still quite high (mean pain of 6.85 [SD=2.34] on a 0–10 
point NRS). This indicates a need for more effective disease 
management as well as the use of a TN-specific measure to 
help assess outcomes. The study findings demonstrate the 
utility of the new Penn-FPS-R for use in future research and 
clinical practice to assess HRQoL. Future studies are needed 
to assess the psychometric properties and cross-cultural 
validity of this newly developed measure. 
Conclusion
Results from this qualitative study were applied to develop 
the Penn-FPS-R, a brief 12-item outcome measure, with 
established content validity that can be used to assess the 
impact of TN pain and treatment outcome in both clinical 
practice and research. 
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